Patents by Inventor Enrique Portillo Salido

Enrique Portillo Salido has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serotonin-norepinephrine reuptake inhibitors (SNRIs) and Sigma receptor ligands combinations
    Patent number: 9931346
    Abstract: The invention refers to a synergistic combination comprising a Sigma ligand of general formula (I), and a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament, particularly for the prophylaxis and/or treatment of pain.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: April 3, 2018
    Assignee: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Daniel Zamanillo-Castanedo, Enrique Portillo-Salido
  • GABAPENTINOIDS AND SIGMA RECEPTOR LIGANDS COMBINATIONS
    Publication number: 20160310501
    Abstract: The invention refers to a synergistic combination comprising a Sigma ligand of general formula (I), and a Gabapentinoid, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament, particularly for the prophylaxis and/or treatment of pain.
    Type: Application
    Filed: December 16, 2014
    Publication date: October 27, 2016
    Inventors: Daniel ZAMANILLO-CASTANEDO, Enrique PORTILLO-SALIDO
  • SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) AND SIGMA RECEPTOR LIGANDS COMBINATIONS
    Publication number: 20160310500
    Abstract: The invention refers to a synergistic combination comprising a Sigma ligand of general formula (I), and a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament, particularly for the prophylaxis and/or treatment of pain.
    Type: Application
    Filed: December 16, 2014
    Publication date: October 27, 2016
    Inventors: Daniel ZAMANILLO-CASTANEDO, Enrique PORTILLO-SALIDO
  • NSAID AND SIGMA RECEPTOR LIGAND COMBINATIONS
    Publication number: 20160220574
    Abstract: The invention refers to a synergistic combination comprising a Sigma ligand, particularly a Sigma ligand of general formula (I), and NSAID compound, a medicament comprising said active substance combination, and the use of said active substance combination for the manufacture of a medicament, particularly for the prophylaxis and/or treatment of pain.
    Type: Application
    Filed: September 11, 2014
    Publication date: August 4, 2016
    Inventors: Daniel ZAMANILLO-CASTANEDO, Enrique PORTILLO-SALIDO, Enrique-José COBOS-DEL-MORAL
  • COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE TREATMENT OF PAIN
    Publication number: 20150150889
    Abstract: The present invention relates to pharmaceutical compositions comprising tramadol and celecoxib and their uses as medicaments or analgesics, more particularly for the treatment of severe to moderate pain with an inflammation component.
    Type: Application
    Filed: February 4, 2015
    Publication date: June 4, 2015
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Enrique PORTILLO SALIDO, Sebastia VIDELA CES
  • COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE TREATMENT OF PAIN
    Publication number: 20140024622
    Abstract: The present invention relates to pharmaceutical compositions comprising tramadol and celecoxib and their uses as medicaments or analgesics, more particularly for the treatment of severe to moderate pain with an inflammation component.
    Type: Application
    Filed: September 25, 2013
    Publication date: January 23, 2014
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Enrique PORTILLO SALIDO, Sebastia VIDELA CES
  • Compositions comprising tramadol and celecoxib in the treatment of pain
    Patent number: 8569271
    Abstract: The present invention relates to pharmaceutical compositions comprising tramadol and celecoxib and their uses as medicaments or analgesics, more particularly for the treatment of severe to moderate pain with an inflammation component.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: October 29, 2013
    Assignee: Laboratorios del Dr. Esteve, S.A.
    Inventors: Enrique Portillo Salido, Sebastia Videla Ces
  • COMPOSITIONS COMPRISING VENLAFAXINE AND CELECOXIB IN THE TREATMENT OF PAIN
    Publication number: 20130072534
    Abstract: The present invention relates to pharmaceutical compositions comprising venlafaxine and celecoxib and their uses as medicaments, more particularly for the treatment of pain, including chronic pain; or of depression in patients which suffer from pain or in patients with a chronic musculo-skeletal inflammatory illness, with the inflammatory illness preferably being selected from osteoarthritis or rheumatoid arthritis.
    Type: Application
    Filed: December 23, 2010
    Publication date: March 21, 2013
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Sebastia Videla Ces, Enrique Portillo Salido
  • COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE TREATMENT OF PAIN
    Publication number: 20120172341
    Abstract: The present invention relates to pharmaceutical compositions comprising tramadol and celecoxib and their uses as medicaments or analgesics, more particularly for the treatment of severe to moderate pain with an inflammation component.
    Type: Application
    Filed: October 15, 2010
    Publication date: July 5, 2012
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Enrique Portillo Salido, Sebastia Videla Ces